Literature DB >> 12005087

Infections diagnosed in the first year after pediatric stem cell transplantation.

Daniel Kelly Benjamin1, William C Miller, Sherry Bayliff, Lisa Martel, Kenneth A Alexander, Paul Langlie Martin.   

Abstract

BACKGROUND: Cumulative incidence of infections in the first year posttransplantation in adult patients has been well-described. Such description is less than complete for pediatric stem cell transplantation (SCT) patients. Further among those patients who have been infected, analysis of risk factors for infection has not been well-described for a large cohort of pediatric SCT patients.
METHODS: We conducted a retrospective cohort study of infections in the first year after SCT at Duke University Medical Center. We recorded all infections in the first year after transplantation. We determined incidences for 6 categories of infection: gram-negative rods; gram-positive cocci; yeast species; Aspergillus sp.; adenovirus; and cytomegalovirus. We determined incidences based on type of transplant and days post transplantation. We also completed bivariable and multivariable analysis of risk factors [neutropenia, graft vs. host disease (GVHD) and GVHD treatment] for infection type among those children who were infected.
RESULTS: We evaluated 510 transplants in 485 children. There were 584 infections in the first year after transplantation. During the first 30 days posttransplantation, type of transplantation did not predict incidence of infection or type of infection. After 30 days children who received unrelated cord blood transplant and matched unrelated donor transplant were at much higher risk of infection than were patients who received autologous, matched sibling or haploidentical transplant (P < 0.001). Patients who received unrelated cord blood or matched unrelated donor transplantation were at higher risk of aspergillosis (P = 0.002), candidiasis (P = 0.005) and adenovirus (P < 0.0001) but not cytomegalovirus (P = 0.18). In analysis of risk factors among those infected, patients with aspergillosis were more likely to have severe GVHD: multivariable 1 year risk ratio, 7.5; 95% confidence interval, 3.0, 18.4. Neutropenia was more strongly associated with gram-negative rod infection than any other type of infection.
CONCLUSIONS: The incidence of infection immediately after transplantation did not differ significantly by type of transplant in this pediatric population. Type of transplant predicted increased incidence of infection 30 days posttransplantation and increased incidence of infection with several organisms traditionally associated with a high mortality rate in the transplant population.

Entities:  

Mesh:

Year:  2002        PMID: 12005087     DOI: 10.1097/00006454-200203000-00013

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  23 in total

1.  Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections.

Authors:  Daniel K Benjamin; Timothy Driscoll; Nita L Seibel; Corina E Gonzalez; Maureen M Roden; Rahki Kilaru; Kay Clark; James A Dowell; Jennifer Schranz; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

2.  Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients.

Authors:  J A Hol; T F W Wolfs; M B Bierings; C A Lindemans; A B J Versluys; A Wildt de; C E Gerhardt; J J Boelens
Journal:  Bone Marrow Transplant       Date:  2013-10-14       Impact factor: 5.483

3.  Safety, tolerability, and feasibility of antifungal prophylaxis with micafungin at 2 mg/kg daily in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.

Authors:  K Yoshikawa; Y Nakazawa; Y Katsuyama; K Hirabayashi; S Saito; T Shigemura; M Tanaka; R Yanagisawa; K Sakashita; K Koike
Journal:  Infection       Date:  2014-02-25       Impact factor: 3.553

4.  The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality.

Authors:  Joshua A Hill; Bryan T Mayer; Hu Xie; Wendy M Leisenring; Meei-Li Huang; Terry Stevens-Ayers; Filippo Milano; Colleen Delaney; Mohamed L Sorror; Brenda M Sandmaier; Garrett Nichols; Danielle M Zerr; Keith R Jerome; Joshua T Schiffer; Michael Boeckh
Journal:  Blood       Date:  2017-02-16       Impact factor: 22.113

5.  Empiric antifungal therapy and outcomes in extremely low birth weight infants with invasive candidiasis.

Authors:  Rachel G Greenberg; Daniel K Benjamin; Marie G Gantz; C Michael Cotten; Barbara J Stoll; Michele C Walsh; Pablo J Sánchez; Seetha Shankaran; Abhik Das; Rosemary D Higgins; Nancy A Miller; Kathy J Auten; Thomas J Walsh; Abbot R Laptook; Waldemar A Carlo; Kathleen A Kennedy; Neil N Finer; Shahnaz Duara; Kurt Schibler; Richard A Ehrenkranz; Krisa P Van Meurs; Ivan D Frantz; Dale L Phelps; Brenda B Poindexter; Edward F Bell; T Michael O'Shea; Kristi L Watterberg; Ronald N Goldberg; P Brian Smith
Journal:  J Pediatr       Date:  2012-03-15       Impact factor: 4.406

Review 6.  Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.

Authors:  Christopher C Dvorak; Brian T Fisher; Lillian Sung; William J Steinbach; Michael Nieder; Sarah Alexander; Theoklis E Zaoutis
Journal:  Pediatr Blood Cancer       Date:  2011-11-18       Impact factor: 3.167

7.  Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease.

Authors:  Holly K Miller; Thomas M Braun; Terri Stillwell; Andrew C Harris; Sung Choi; James Connelly; Daniel Couriel; Steven Goldstein; Carrie L Kitko; John Magenau; Attaphol Pawarode; Pavan Reddy; Mary Riwes; Gregory A Yanik; John E Levine
Journal:  Biol Blood Marrow Transplant       Date:  2016-12-22       Impact factor: 5.742

8.  Early infections after autologous hematopoietic stem cell transplantation in children and adolescents: the St. Jude experience.

Authors:  A Srinivasan; L McLaughlin; C Wang; D K Srivastava; D R Shook; W Leung; R T Hayden
Journal:  Transpl Infect Dis       Date:  2013-11-21       Impact factor: 2.228

9.  Automated and manual methods of DNA extraction for Aspergillus fumigatus and Rhizopus oryzae analyzed by quantitative real-time PCR.

Authors:  Andrea Francesconi; Miki Kasai; Susan M Harrington; Mara G Beveridge; Ruta Petraitiene; Vidmantas Petraitis; Robert L Schaufele; Thomas J Walsh
Journal:  J Clin Microbiol       Date:  2008-03-19       Impact factor: 5.948

10.  Galactomannan antigenemia in pediatric oncology patients with invasive aspergillosis.

Authors:  Randall Hayden; Stanley Pounds; Katherine Knapp; Ruta Petraitiene; Robert L Schaufele; Tin Sein; Thomas J Walsh
Journal:  Pediatr Infect Dis J       Date:  2008-09       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.